Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00388414 · ClinicalTrials.gov registry record · NA

Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
14
Enrollment target

NCT00388414: Completed NA study, sponsored by Stanford University.

NCT00388414 is a NA study that has completed, run by Stanford University. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00388414, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

Duloxetine has recently been shown to be effective in reducing the pain in chronic pain patients. Duloxetine is known to exert a central mechanism, however the precise human brain structures responsible for mediating its pain-relieving properties are not known. We will use functional magnetic resonance imaging (FMRI) to investigate the neural and functional correlates of pain.

Interventions

  • DRUG Placebo
  • DRUG duloxetine

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2006-09
Est. Completion 2010-01
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT00388414

The ClinicalTrials.gov registry entry for NCT00388414 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT00388414 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00388414 about?

NCT00388414 is a clinical study titled "Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication". Duloxetine has recently been shown to be effective in reducing the pain in chronic pain patients. Duloxetine is known to exert a central mechanism, however the precise human brain structures responsible for mediating its pain-relieving properties are not known. We will use functional magnetic resona...

What is the current status of trial NCT00388414?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2006-09. Estimated completion is 2010-01.

What interventions are being tested in trial NCT00388414?

The interventions under investigation include: Placebo (DRUG), duloxetine (DRUG).

Who is sponsoring clinical trial NCT00388414?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.